Ardent Health, Inc. ARDT
14.50 USD +0.10 (+0.69%)
Regular-session close
14.50 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
14.10 Day range 14.67
7.71 52-week range 18.57
- YTD
- +64.21%
- 1 year
- +68.02%
News
businesswire.com Eight Ardent Health Facilities Earn ‘A' Hospital Safety Grades from The Leapfrog Group for Fall 2026 Grading Period BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that eight of its facilities…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers Akanda (NASDAQ:AKAN) shares rose 66.8% to $3.42 during Wednesday's regular session. The market value of their outstanding shares is at $5.4 million. Cue Biopharma (NASDAQ:CUE) shares rose…
benzinga.com Ardent Health Stock Tumbles 14.61% After Hours: Here's Why Ardent Health shares slide after hours following $14.50 secondary offering pricing and concurrent share repurchase.
businesswire.com Ardent Health Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”) today announced the pricing of the previously announced secondary public offering (the…
businesswire.com CORRECTING and REPLACING Ardent Health Announces Proposed Secondary Offering of Common Stock and Concurrent Share Repurchase BRENTWOOD, Tenn.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: ARDENT HEALTH ANNOUNCES PROPOSED SECONDARY…
businesswire.com Ardent Health Announces Proposed Secondary Offering of Common Stock and Concurrent Share Repurchase BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”) today announced the commencement of a proposed secondary public offering (the “Offering”) of…benzinga.com Truist Securities Maintains Buy on Ardent Health, Raises Price Target to $22 Truist Securities analyst David Macdonald maintains Ardent Health (NYSE:ARDT) with a Buy and raises the price target from $13 to $22.
seekingalpha.com Ardent Health, Inc. (ARDT) M&A Call Transcript Ardent Health, Inc. (ARDT) M&A Call Transcriptbenzinga.com B of A Securities Maintains Underperform on Ardent Health, Raises Price Target to $14 B of A Securities analyst Kevin Fischbeck maintains Ardent Health (NYSE:ARDT) with a Underperform and raises the price target from $12 to $14.
benzinga.com Ardent Health Agrees To Acquire Boone Health For Purchase Price Of $47M In Cash Expands Ardent’s footprint into an attractive mid-sized Missouri market with a scaled health system that generates ~$480 million of annual revenue1Provides $200 million capital commitment over 10…
businesswire.com Ardent Health Announces Definitive Agreement to Acquire Boone Health BRENTWOOD, Tenn. & COLUMBIA, Mo.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced a definitive…benzinga.com Stephens & Co. Maintains Overweight on Ardent Health, Raises Price Target to $21 Stephens & Co. analyst Scott Fidel maintains Ardent Health (NYSE:ARDT) with a Overweight and raises the price target from $13 to $21.
benzinga.com RBC Capital Maintains Outperform on Ardent Health, Raises Price Target to $18 RBC Capital analyst Ben Hendrix maintains Ardent Health (NYSE:ARDT) with a Outperform and raises the price target from $13 to $18.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Lakewood-Amedex (NASDAQ:LABT) shares moved upwards by 237.6% to $0.65 during Thursday's regular session. ADMA Biologics (NASDAQ:ADMA) stock increased by 25.62% to $13.16. The market value of…
benzinga.com Ardent Health Partners Q3 2026 Earnings Call Transcript Ardent Health Partners (NYSE:ARDT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…benzinga.com Ardent Health Raises FY2026 GAAP EPS Guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.463B Est Ardent Health (NYSE:ARDT) raises FY2026 GAAP EPS guidance from $0.78-$1.15 to $0.93-$1.18 vs $0.95 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400…
benzinga.com Ardent Health Partners Q3 EPS $0.31 Beats $0.22 Estimate, Sales $1.624B Beat $1.603B Estimate Ardent Health Partners (NYSE:ARDT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.22 by 40.91 percent. This is a 282.35 percent increase over losses of…
